Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 835-838

  Slanař, Ondřej ^a,c   Bortlík, Martin ^b   Buzková, Helena ^a   Donoval, Robert ^b   Pechandová, Kristina ^a   Šebesta, Ivan ^a   Lukáš, Milan ^b   Perlík, František ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ISCARE as   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Azathioprine; Pharmacogenetics; Polymorphism; Thiopurine S methyltransferase

Indexed keywords

AZATHIOPRINE; THIOPURINE METHYLTRANSFERASE;

ALLELE; CONFERENCE PAPER; CONTROLLED STUDY; CZECH REPUBLIC; DNA POLYMORPHISM; ENTERITIS; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE;

AZATHIOPRINE; CASE-CONTROL STUDIES; CZECH REPUBLIC; GENE FREQUENCY; GENOTYPE; HEALTH; HUMANS; INFLAMMATORY BOWEL DISEASES; METHYLTRANSFERASES; POLYMORPHISM, GENETIC;

EID: 46749130445     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802146478     Document Type: Conference Paper

References (11)

1. Tidd, D.M.; Paterson A.R. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res. 1974, 34, 738-746.
2. Weinshilboum, R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab. Dispos. 2001, 29, 601-605.
3. Schaeffeler, E.; Eichelbaum, M.; Reinisch, W.; Zanger, U.M.; Schwab, M. Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme function. Hum Mutat. 2006, 27(9), 976-984.
4. Wei, H.; Zhou, S.; Li, C.; Zhang, J.; Wu, J.; Huang, M. Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks. Pharm. Res. 2005, 22(10), 1762-1766.
5. Yates, C.R.; Krynetski, E.Y.; Loennechen, T.; Fessing, M.Y.; Tai, H.L.; et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 1997, 126, 608-614.
6. Ameyaw, M.M.; Collie-Duguid, E.S.; Powrie, R.H.; Ofori-Adjei, D.; McLeod, H.L. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum. Mol Genet. 1999, 8, 367-370.
7. Haglund, S.; Lindqvist, M.; Almer, S.; Peterson, C.; Taipalensuu, J. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin. Chem. 2004, 50, 288-295.
8. McLeod, H.L.; Pritchard, S.C.; Githang'a, J.; Indalo, A.; Ameyaw, M.M.; et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 1999, 9, 773-776.
9. Tai, H.L.; Krynetski, E.Y.; Yates, C.R.; Loennechen, T.; Fessing, M.Y.; et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am. J. Hum. Genet. 1996, 58, 694-702.
10. Schaeffeler, E.; Fischer, C.; Brockmeier, D.;Wernet, D.;Moerike, K.; et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004, 14, 407-417.
11. Toft, N.; Nygaard, U.; Gregers, J.; Schmiegelow, K. Genetic analyses of thiopurine methyltransferase polymorphisms in Greenlandic and Danish populations. Acta Paediatr. 2006, 95, 1665-1667.